Market Tracker

11/21 6:05pm ET

Isis Pharmaceuticals Inc (NASDAQ:ISIS)

50.94
Data as of Nov 21
 -0.68 / -1.32%
Today’s Change
22.25
Today|||52-Week Range
62.66
+27.86%
Year-to-Date

Today’s Trading

Previous close51.62
Today’s open52.02
Day’s range50.75 - 52.58
Volume1,531,035
Average volume (3 months)2,425,204
Market cap$6.1B
Dividend yield--
Data as of 3:59pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)+15.38%
Earnings growth (this year)-16.77%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+44.33%
P/E ratioNM
Price/Sales29.89
Price/Book15.89

Competitors

 Today’s
change
Today’s
% change
CBSTCubist Pharmaceutica...+0.23+0.31%
ALNYAlnylam Pharmaceutic...+1.98+2.21%
QQuintiles Transnatio...+0.11+0.19%
ICLRICON PLC+0.36+0.66%
Data as of 4:14pm ET, 11/21/2014

Financials

Next reporting dateMarch 2, 2015
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$147.3M
Annual profit (last year)-$60.6M
Net profit margin-41.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Stanley T. Crooke
Chief Operating Officer, Secretary &
Director
B. Lynne Parshall
Corporate headquarters
Carlsbad, California

Forecasts